{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:34:00Z","timestamp":1794411240418,"version":"4.9.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100023448","name":"Robert Koch-Institut","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100023448","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In Germany, general childhood varicella vaccination has been recommended since 2004. A feared effect of low vaccination coverage is a possible shift in incidence from children to teenagers and young adults who are at higher risk of severe outcomes. If true, this shift would possibly necessitate changes to the national immunization strategy.<\/jats:p>\n                    <jats:p>We aimed to evaluate the effects of the general vaccination recommendation on age-specific varicella incidences in Germany in general and examine specifically whether a shift from children to teenagers (15 to 19\u00a0years) has occurred.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Trends in age-specific incidences were evaluated using triangulation with the following datasets: national mandatory notification data (\n                      <jats:italic>N)<\/jats:italic>\n                      (2014\u20132022), billing data of the statutory health insurance associations (\n                      <jats:italic>I<\/jats:italic>\n                      ) (2009\u20132017) and data from a doctor's sentinel system (\n                      <jats:italic>S<\/jats:italic>\n                      ) (2006\u20132017). Similar clinical case definitions were used in\n                      <jats:italic>N<\/jats:italic>\n                      and\n                      <jats:italic>S<\/jats:italic>\n                      , while\n                      <jats:italic>I<\/jats:italic>\n                      used ICD-10-codes. Age groups were stratified as available in all three systems. Incidences per year were calculated based on the total population (\n                      <jats:italic>N<\/jats:italic>\n                      ), the number of statutory health insured (\n                      <jats:italic>I)<\/jats:italic>\n                      , and extrapolated from\n                      <jats:italic>S<\/jats:italic>\n                      to the total population.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During all years of observation, age-specific incidences have dropped significantly across all age-groups for\n                      <jats:italic>S<\/jats:italic>\n                      und\n                      <jats:italic>I.<\/jats:italic>\n                      The age groups (under 10\u00a0years) with initially highest incidences were the ones with the strongest reductions (under 1\u00a0year: -90%, 1\u20134\u00a0years: -95.5%, 5\u20139\u00a0years: -89.2% for\n                      <jats:italic>S<\/jats:italic>\n                      ; -67.7%, -78%, -79.3% for\n                      <jats:italic>I<\/jats:italic>\n                      ). A single 53.1% increase in the low incidence in\n                      <jats:italic>S<\/jats:italic>\n                      among 15\u201319-year olds observed in 2017 compared to 2016 could not be confirmed in\n                      <jats:italic>N<\/jats:italic>\n                      or\n                      <jats:italic>I<\/jats:italic>\n                      . Increases in incidences during the first two years of\n                      <jats:italic>N<\/jats:italic>\n                      are probably due to improved notification behaviour over these years. In 2019, all age-specific incidences increased (\n                      <jats:italic>N<\/jats:italic>\n                      ), with 15 to 19-year olds showing the highest relative increase (28.2%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Since the introduction of the general vaccine recommendation against varicella, incidences across all age-groups have declined significantly. Available data indicate no evidence for a shift in disease incidence to older age groups. Every incidence increase beyond childhood age should however be followed up closely. So far, children and adolescents have both benefitted from the current vaccination strategy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-023-17098-1","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T22:01:50Z","timestamp":1699394510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Trends in age-specific varicella incidences following the introduction of the general recommendation for varicella immunization in Germany, 2006\u20132022"],"prefix":"10.1186","volume":"23","author":[{"given":"Felix","family":"Moek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Siedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"key":"17098_CR1","first-page":"421","volume":"49","author":"Robert Koch Institute","year":"2004","unstructured":"Robert Koch Institute. Zur Varizellenimpfung. Epid Bull. 2004;49:421\u20135.","journal-title":"Epid Bull"},{"key":"17098_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.25646\/10838","volume":"48","author":"T Rieck","year":"2022","unstructured":"Rieck T, Feig M, Siedler A. Impfquoten von Kinderschutzimpfungen in Deutschland \u2013 aktuelle Ergebnisse aus der RKI-Impfsurveillance. Epid Bull. 2022;48:3\u201325. https:\/\/doi.org\/10.25646\/10838.","journal-title":"Epid Bull"},{"issue":"45","key":"17098_CR3","doi-asserted-by":"publisher","first-page":"7866","DOI":"10.1016\/j.vaccine.2007.07.036","volume":"25","author":"A Nardone","year":"2007","unstructured":"Nardone A, de Ory F, Carton M, Cohen D, van Damme P, Davidkin I, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine. 2007;25(45):7866\u201372.","journal-title":"Vaccine"},{"issue":"7","key":"17098_CR4","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1080\/21645515.2018.1446718","volume":"14","author":"B Zoch-Lesniak","year":"2018","unstructured":"Zoch-Lesniak B, Tolksdorf K, Siedler A. Trends in herpes zoster epidemiology in Germany based on primary care sentinel surveillance data, 2005\u20132016. Hum Vaccines Immunother. 2018;14(7):1807\u201314.","journal-title":"Hum Vaccines Immunother"},{"key":"17098_CR5","first-page":"111","volume":"13","author":"Robert Koch Institute","year":"2005","unstructured":"Robert Koch Institute. AGM\/V: Masern-Sentinel (AGM) wird durch Sentinel der Varizellen erg\u00e4nzt. Epid Bull. 2005;13:111\u20132.","journal-title":"Epid Bull"},{"issue":"2","key":"17098_CR6","doi-asserted-by":"publisher","first-page":"476","DOI":"10.4161\/hv.26986","volume":"10","author":"T Rieck","year":"2014","unstructured":"Rieck T, Feig M, Eckmanns T, Benzler J, Siedler A, Wichmann O. Vaccination coverage among children in Germany estimated by analysis of health insurance claims data. Hum Vaccines Immunother. 2014;10(2):476\u201384.","journal-title":"Hum Vaccines Immunother"},{"key":"17098_CR7","unstructured":"Robert Koch Institute. Infektionsepidemiologisches Jahrbuch f\u00fcr 2018. Available from: https:\/\/www.rki.de\/DE\/Content\/Infekt\/Jahrbuch\/Jahrbuch_2018.pdf?__blob=publicationFile."},{"key":"17098_CR8","unstructured":"Die Datenbank des Statistischen Bundesamtes. Available from: https:\/\/www-genesis.destatis.de\/genesis\/\/online\/data?operation=ergebnistabelleAnzeigen&index=0&levelindex=0&levelid=1572543673941."},{"key":"17098_CR9","unstructured":"SurvStat@RKI 2.0. Available from: https:\/\/survstat.rki.de\/."},{"issue":"5","key":"17098_CR10","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1001\/jama.287.5.606","volume":"287","author":"JF Seward","year":"2002","unstructured":"Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995\u20132000. JAMA. 2002;287(5):606\u201311.","journal-title":"JAMA"},{"issue":"34","key":"17098_CR11","doi-asserted-by":"publisher","first-page":"902","DOI":"10.15585\/mmwr.mm6534a4","volume":"65","author":"AS Lopez","year":"2016","unstructured":"Lopez AS, Zhang J, Marin M. Epidemiology of varicella during the 2-dose varicella vaccination program - United States, 2005\u20132014. MMWR Morb Mortal Wkly Rep. 2016;65(34):902\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"42","key":"17098_CR12","doi-asserted-by":"publisher","first-page":"4744","DOI":"10.1016\/j.vaccine.2013.08.022","volume":"31","author":"A Waye","year":"2013","unstructured":"Waye A, Jacobs P, Tan B. The impact of the universal infant varicella immunization strategy on Canadian varicella-related hospitalization rates. Vaccine. 2013;31(42):4744\u20138.","journal-title":"Vaccine"},{"issue":"8","key":"17098_CR13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.2471\/BLT.13.132142","volume":"92","author":"AE Heywood","year":"2014","unstructured":"Heywood AE, Wang H, Macartney KK, McIntyre P. Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study. Bull World Health Organ. 2014;92(8):593\u2013604.","journal-title":"Bull World Health Organ"},{"key":"17098_CR14","doi-asserted-by":"crossref","unstructured":"Boccalini S, Bonanni P, Bechini A. Preparing to introduce\u00a0 the varicella vaccine into the Italian immunisation programme: varicella-related hospitalisations in Tuscany, 2004\u20132012. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2016;21(24).\u00a0https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2016.21.24.30257.","DOI":"10.2807\/1560-7917.ES.2016.21.24.30257"},{"issue":"3","key":"17098_CR15","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1080\/21645515.2020.1788861","volume":"17","author":"A Soysal","year":"2021","unstructured":"Soysal A, G\u00f6n\u00fcll\u00fc E, Y\u0131ld\u0131z \u0130, Karab\u00f6c\u00fco\u011flu M. Incidence of varicella and herpes zoster after inclusion of varicella vaccine in national immunization schedule in Turkey: time trend study. Hum Vaccines Immunother. 2021;17(3):731\u20137.","journal-title":"Hum Vaccines Immunother"},{"issue":"3","key":"17098_CR16","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1080\/21645515.2018.1546525","volume":"15","author":"FH Varela","year":"2019","unstructured":"Varela FH, Pinto LA, Scotta MC. Global impact of varicella vaccination programs. Hum Vaccines Immunother. 2019;15(3):645\u201357.","journal-title":"Hum Vaccines Immunother"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-17098-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-023-17098-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-17098-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T22:02:20Z","timestamp":1699394540000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-023-17098-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["17098"],"URL":"https:\/\/doi.org\/10.1186\/s12889-023-17098-1","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,8]]},"assertion":[{"value":"27 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No new information on patients was gathered. All data analyzed had already been collected at the time the study had started. All data used had either already been pseudonymized before being sent to the RKI (Countrywide notification system data and statutory health insurance claims data) or were collected as aggregated data (number of cases per month per practice, by age group) in case of the Sentinel data. The group size of each aggregated data unit was so big that it did not allow for inferences concerning any individual case included. Informed consent and ethical committee clearance had already been attained for the Sentinel and statutory health insurance claims data before those data were collected.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2191"}}